🔗 Visit the ClinicalTrials.gov page for NCT03213639
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. | Am J Obstet Gynecol | 2008 | 1.12 |
| 2 | Early serum markers of pre-eclampsia: are we stepping forward? | J Matern Fetal Neonatal Med | 2015 | 0.80 |
| 3 | Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol. | BMJ Open | 2015 | 0.75 |